OBJECTIVE: In current, neonatal practice, clinical signs of intrauterine infection (IUI) are often non-specific. From a large panel of immune biomarkers, we seek to identify cord blood markers that are most strongly associated with the fetal inflammatory response (FIR), a specific placental lesion associated with serious neonatal complications. METHODS: We used multiplex immunoassay to measure 27 biomarkers, selected as part of an NIH-funded study of preterm birth, according to gestational age (GA) and extent of placental inflammation: involvement of chorion, amnion, decidua (maternal inflammatory response, MIR); extension to umbilical cord or chorionic plate (FIR). We used false-discovery rate (FDR < 5%, P < 0.001) to account for multiple comparisons. RESULTS: Among 506 births (GA 23-42 weeks), IL-1 beta increased with FIR among preterm subgroups (P = 0.0001 for <32 weeks; P = 0.0009 for 33-36 weeks). IL-6 and IL-8 increased with FIR among preterm and full-term infants (P < 0.0001). P-trend for IL-6 and IL-8 with MIR versus FIR was <0.0001. Comparison with respect to clinical IUI yielded persistent elevation with FIR even when clinical signs were absent. The remaining 24 markers were not significantly associated. CONCLUSION: We conclude that among 27 cord blood biomarkers, IL-1 beta, IL-6 and IL-8 are selectively associated with FIR. These markers may be clinically useful indicators of extensive IUI associated with poor neonatal outcome.
OBJECTIVE: In current, neonatal practice, clinical signs of intrauterine infection (IUI) are often non-specific. From a large panel of immune biomarkers, we seek to identify cord blood markers that are most strongly associated with the fetal inflammatory response (FIR), a specific placental lesion associated with serious neonatal complications. METHODS: We used multiplex immunoassay to measure 27 biomarkers, selected as part of an NIH-funded study of preterm birth, according to gestational age (GA) and extent of placental inflammation: involvement of chorion, amnion, decidua (maternal inflammatory response, MIR); extension to umbilical cord or chorionic plate (FIR). We used false-discovery rate (FDR < 5%, P < 0.001) to account for multiple comparisons. RESULTS: Among 506 births (GA 23-42 weeks), IL-1 beta increased with FIR among preterm subgroups (P = 0.0001 for <32 weeks; P = 0.0009 for 33-36 weeks). IL-6 and IL-8 increased with FIR among preterm and full-term infants (P < 0.0001). P-trend for IL-6 and IL-8 with MIR versus FIR was <0.0001. Comparison with respect to clinical IUI yielded persistent elevation with FIR even when clinical signs were absent. The remaining 24 markers were not significantly associated. CONCLUSION: We conclude that among 27 cord blood biomarkers, IL-1 beta, IL-6 and IL-8 are selectively associated with FIR. These markers may be clinically useful indicators of extensive IUI associated with poor neonatal outcome.
Authors: O Dammann; T M Phillips; E N Allred; T M O'Shea; N Paneth; L J Van Marter; C Bose; R A Ehrenkranz; F J Bednarek; M Naples; A Leviton Journal: Cytokine Date: 2001-02-21 Impact factor: 3.861
Authors: R Romero; R Gomez; M Galasso; H Munoz; L Acosta; B H Yoon; D Svinarich; D B Cotton Journal: Am J Reprod Immunol Date: 1994-09 Impact factor: 3.886
Authors: S Nadya J Kazzi; Suzanne M Jacques; Faisal Qureshi; Michael W Quasney; U Olivia Kim; Irina A Buhimschi Journal: Pediatr Res Date: 2004-05-05 Impact factor: 3.756
Authors: Ingrid Hansen-Pupp; Anne-Li Hallin; Lena Hellström-Westas; Corrado Cilio; Ann-Cathrine Berg; Karin Stjernqvist; Vineta Fellman; David Ley Journal: Pediatr Res Date: 2008-08 Impact factor: 3.756
Authors: Jonathan L Hecht; Raina N Fichorova; Vanessa F Tang; Elizabeth N Allred; Thomas F McElrath; Alan Leviton Journal: Pediatr Res Date: 2011-01 Impact factor: 3.756
Authors: Roberto Romero; Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Stanley M Berry; Juan Pedro Kusanovic; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor Journal: J Perinat Med Date: 2011-09-30 Impact factor: 1.901
Authors: Fiona M O'Hare; William Watson; Amanda O'Neill; Tim Grant; Chike Onwuneme; Veronica Donoghue; Eoghan Mooney; Paul Downey; John Murphy; Anne Twomey; Eleanor J Molloy Journal: Pediatr Res Date: 2015-03-31 Impact factor: 3.756
Authors: N Matoba; F Ouyang; K K L Mestan; N F M Porta; C M Pearson; K M Ortiz; H C Bauchner; B S Zuckerman; X Wang Journal: J Dev Orig Health Dis Date: 2011-04 Impact factor: 2.401
Authors: Suhas G Kallapur; Pietro Presicce; Cesar M Rueda; Alan H Jobe; Claire A Chougnet Journal: Semin Reprod Med Date: 2014-01-03 Impact factor: 1.303
Authors: Tinnakorn Chaiworapongsa; Roberto Romero; Stanley M Berry; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor Journal: J Perinat Med Date: 2011-07-30 Impact factor: 1.901
Authors: Amanda L Prince; Jun Ma; Paranthaman S Kannan; Manuel Alvarez; Tate Gisslen; R Alan Harris; Emma L Sweeney; Christine L Knox; Donna S Lambers; Alan H Jobe; Claire A Chougnet; Suhas G Kallapur; Kjersti M Aagaard Journal: Am J Obstet Gynecol Date: 2016-03-07 Impact factor: 8.661
Authors: Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Noppadol Chaiyasit; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo; Yeon Mee Kim Journal: J Perinat Med Date: 2016-01 Impact factor: 1.901